Loss of basement membrane heparan sulfate expression is associated with tumor progression in endometrial cancer

European Journal of Gynaecological Oncology

Volumn 26, Issue 4, 2005, Pages 403-406

  Hasengaowa, ^a   Kodama, J ^a   Kusumoto, T ^a   Shinyo, Y ^a   Seki, N ^a   Nakamura, K ^a   Hongo, A ^a   Hiramatsu, Y ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Basement membrane; Endometrial cancer; Heparan sulfate

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARAN SULFATE GLYCOSAMINOGLYCAN; PERLECAN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; BASEMENT MEMBRANE; BINDING AFFINITY; CANCER GRADING; CANCER INVASION; CARBOHYDRATE METABOLISM; CLINICAL FEATURE; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MYOMETRIUM; PROGNOSIS; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; BASEMENT MEMBRANE; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, ENDOMETRIOID; DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING;

EID: 23744468224     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bernfield M., Gotte M., Park P.W., Reizes O., Fitzgerald M.L., Lincecum J. et al.: "Functions of cell surface heparan sulfate proteoglycans". Annu. Rev. Biochem., 1999, 68, 729.
2. Yanagishita M., Hascall V.C.: "Cell surface heparan sulfate proteoglycans". J. Biol. Chem., 1992, 267, 9451.
3. Jiang X., Couchman J.R.: "Perlecan and tumor angiogenesis". J. Histochem. Cytochem., 2003, 57, 1393.
4. Nakajima M., Irimura T., Di Ferrante N., Nicolson G.L.: "Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase". J. Biol. Chem., 1984, 259, 2283.
5. Simizu S., Ishida K., Osada H.: "Heparanase as a molecular target of cancer chemotherapy". Cancer Sci., 2004, 95, 553.
6. Uno F., Fujiwara T., Takata Y., Ohtani S., Katsuda K., Takaoka M. et al.: "Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells". Cancer Res., 2001, 61, 7855.
7. Parish C.R., Freeman C., Brown K.J., Francis D.J., Cowden W.B.: "Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity". Cancer Res., 1999, 59, 3433.
8. Shinyo Y., Kodama J., Kongo A., Yoshinouchi M., Hiramatsu U.: "Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer". Ann. Oncol., 2003, 14, 1505.
9. Vlodavsky I., Friedmann Y., Elkin M., Aingorn H., Atzmon R., Ishai-Michaeli R. et al.: "Mammalian heparanse: gene cloning, expression and function in tumor progression and metastasis". Nat. Med., 1999, 5, 793.
10. Blackball F.H., Merry C.L.R., Davies E.J., Jayson G.C.: "Heparan sulfate proteoglycans and cancer". Brit. J. Cancer, 2001, 85, 1094.
11. Kodama J., Shinyo Y., Hasengaowa, Kusumoto T., Seki N., Nakamura K. et al.: "Loss of basement membrane heparan sulfate expression is associated with pelvic lymph node metastasis in invasive cervical cancer". Oncol. Rep. (in press).
12. Xu X., Quiros R.M., Maxhimer J.B., Jiang P., Marcinek R., Ain K.B. et al.: "Inverse correlation between heparan sulfate composition and heparanase-1 expression in thyroid papillary carcinomas: a potential role in tumor metastasis". Clin. Cancer Res., 2003, 9, 5968.
13. Reiland J., Sanderson R.D., Waguespack M., Barker S.A., Long R., Carson D.D. et al: "Heparanase degrade syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion". J. Biol. Chem., 2004, 27, 8047.